Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Mastocytosis, Systemic 1Mastocytosis 1

Interventions

masitinib 3Imatinib Mesylate 3fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Transplantation 1Tacrolimus 1Stem Cell Transplantation 1Sodium Chloride 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Injections 1Dasatinib 1Cyclophosphamide 1Busulfan 1BNT162 Vaccine 1AK002 12019-nCoV Vaccine mRNA-1273 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mastocytosis × AK002 × Clear all
NCT02808793 2019-03-13

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002

Allakos Inc.

Phase 1 Completed
25 enrolled
Myeloid

Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡